CorMedix CRMD and Theravance Biopharma TBPH occupy a similar niche in the market as small-cap biopharmaceutical companies working to turn promising science into sustainable revenues. Both companies, ...

Explore how oncology data season is drawing attention to Nuvation Bio, Arcus Biosciences, and smaller cancer-focused biotech developers.

The S&P/ASX Small Ordinaries Index (XSO) closed at 3,553.80 yesterday, up 0.087% or 3.10 points. The index has gained 4.36% over the past five days, adding 148.50 points as small-cap investor ...

In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds. On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer ...

The S&P/ASX Small Ordinaries Index (ASX: XSO) closed at 3,562.70, down 1.18% or 42.60 points yesterday. Despite the daily ...

The S&P/ASX Small Ordinaries Index (ASX: XSO) closed at 3,390.60, down 6.60 points or 0.19% in the latest session. The index has fallen 2.10% over the past five trading days, reflecting ongoing ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Small-cap stocks are coming off a historic run. On Tuesday, they clinched their best performance during the first six months ...

From broad domestic exposure to global pharma and biotech, these funds cover the healthcare sector's main themes.